Variable Phenotypic Manifestations of Novel Compound Heterozygous CRPPA Variants in Two Iranian Siblings With Limb‐Girdle Muscular Dystrophy
Molecular Genetics & Genomic Medicine · 2026
DOI: 10.1002/mgg3.70312 ↗Kurz gefasst
Fallbericht in der Zeitschrift Molecular Genetics & Genomic Medicine, 2026. Verfasst von Parnian Alagha und 9 weiteren Autor:innen. Beteiligte Einrichtung: Kariminejad - Najmabadi Pathology & Genetics Center, Tehran, Iran. Hauptthemen laut MEDLINE: Muscular Dystrophies, Limb-Girdle, Phenotype, Nucleotidyltransferases. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Genetics Research Center, University of Social Welfare and Rehabilitation Sciences and Kariminejad - Najmabadi Pathology & Genetics Center, Tehran, Iran.
Abstract (Originalsprache)
Background
Dystroglycanopathies are a clinically and genetically heterogeneous group of muscular dystrophies caused by impaired glycosylation of α ‐dystroglycan, with variants in multiple genes, including CRPPA , which is associated with a broad spectrum ranging from congenital muscular dystrophy to limb‐girdle muscular dystrophy.
Method
The proband underwent whole exome sequencing, while Sanger sequencing was used for segregation analysis and oligonucleotide array‐CGH was performed to confirm the copy number variant.
Results
We report two siblings harboring an identical novel compound heterozygous CRPPA genotype, comprising a novel c.267G>C missense variant and a deletion encompassing exons 9–10. Despite sharing the same genotype, the siblings showed marked phenotypic variability. The female sibling developed childhood‐onset disease with proximal weakness involving both the upper and lower limbs, whereas the male sibling presented with late‐onset disease and weakness confined to the proximal lower limbs, accompanied by markedly discordant serum creatine kinase levels (1193 vs. 460 U/L).
Conclusion
These findings expand the mutational and clinical spectrum of CRPPA‐related dystroglycanopathy, highlight marked intrafamilial phenotypic variability, and emphasize the importance of integrated single‐nucleotide and copy number variant analysis in the genetic diagnosis of neuromuscular disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Kariminejad - Najmabadi Pathology & Genetics Center, Tehran, Iran.
- Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
- Neuromuscular Research Center, Tehran University of Medical Sciences, Tehran, Iran.
ORCID-Profile: Parnian Alagha, Ariana Kariminejad, Aida Ghasemi, Roxana Kariminejad, Kimia Kahrizi, Ali Asghar Okhovat, Hossein Najmabadi
Förderung
- Genetics Research Center, University of Social Welfare and Rehabilitation Sciences and Kariminejad - Najmabadi Pathology & Genetics Center, Tehran, Iran
Zitieren
APA
Alagha, P., Ahangari, F., Kariminejad, A., Ghasemi, A., Gholami, S., Sadatian, N., Kariminejad, R., Kahrizi, K., Okhovat, A. A., & Najmabadi, H. (2026). Variable Phenotypic Manifestations of Novel Compound Heterozygous CRPPA Variants in Two Iranian Siblings With Limb‐Girdle Muscular Dystrophy. Molecular Genetics & Genomic Medicine. https://doi.org/10.1002/mgg3.70312
Vancouver
Alagha P, Ahangari F, Kariminejad A, Ghasemi A, Gholami S, Sadatian N, et al. Variable Phenotypic Manifestations of Novel Compound Heterozygous CRPPA Variants in Two Iranian Siblings With Limb‐Girdle Muscular Dystrophy. Molecular Genetics & Genomic Medicine. 2026. doi:10.1002/mgg3.70312
BibTeX
@article{Alagha2026,
author = {Alagha, Parnian and Ahangari, Fatemeh and Kariminejad, Ariana and Ghasemi, Aida and Gholami, Soheila and Sadatian, Neda and Kariminejad, Roxana and Kahrizi, Kimia and Okhovat, Ali Asghar and Najmabadi, Hossein},
title = {Variable Phenotypic Manifestations of Novel Compound Heterozygous CRPPA Variants in Two Iranian Siblings With Limb‐Girdle Muscular Dystrophy},
journal = {Molecular Genetics & Genomic Medicine},
year = {2026},
doi = {10.1002/mgg3.70312}
}
EUVIMED